Photo by Fusion Medical Animation on Unsplash
Greg Duncan, Chairman and CEO of Virios Therapeutics Inc. VIRI, was a guest speaker at Benzinga’s All Access on Jan. 28, 2022.
Greg discussed Virios Therapeutics’ mission and the clinical-stage company’s ongoing progress in developing innovative antiviral therapies to treat diseases - like fibromyalgia (FM) and related health concerns.
Watch the full interview here.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in